General Information of the Compound
| Compound ID |
CP0085039
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2,N-Dihydroxy-benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
2,N-Dihydroxy-benzamide
2-Hydroxybenzhydroxamic acid
2-Hydroxybenzohydroxamic acid
2-hydroxybenzenecarbohydroxamic acid
89-73-6
Benzamide, N,2-dihydroxy-
CHEBI:45615
CHEMBL309339
EINECS 201-934-3
MLS000069410
N,2-Dihydroxybenzamide
NSC 193440
NSC 5088
NSC5088
O-Hydroxybenzohydroxamic acid
SHA
SHAM
Saliaylhydroxamic acid
SalicylhydroxaMicacid
Salicylhydroxamic acid
Salicylhydroxamic acid, 99%
Salicylic Hydroxamic Acid
Salicylohydroxamic acid
Salicylohydroximic acid
UNII-8Q07182D0T
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C7H7NO3
|
||||||||||||||||||
| Molecular Weight |
153.137
|
||||||||||||||||||
| Canonical SMILES |
ONC(=O)c1ccccc1O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HBROZNQEVUILML-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
89-73-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound